![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Fsp Galena Wroclaw Pl, based in Poland, is a pharmaceutical company.
One of their significant offerings is Etamsylate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2008-317 - Rev 04
This Chemical Type CEP, issued on October 28, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1204 associated with this CEP further emphasizes